From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage

Title
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage
Authors
Keywords
Complement dysregulation, C3 convertase, AMY-101, Clinical efficacy, Primate models, Peptidic C3 inhibitors
Journal
IMMUNOBIOLOGY
Volume 221, Issue 10, Pages 1046-1057
Publisher
Elsevier BV
Online
2016-06-21
DOI
10.1016/j.imbio.2016.06.013

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started